CA Patent

CA3026006C — Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy

Assigned to Amarin Pharmaceuticals Ireland Ltd · Expires 2021-09-07 · 5y expired

What this patent protects

In various embodiments, the present invention provides eicosapentaenoate (EPA) compositions and methods for treating and/or preventing cardiovascular-related diseases in a subject in need thereof.

USPTO Abstract

In various embodiments, the present invention provides eicosapentaenoate (EPA) compositions and methods for treating and/or preventing cardiovascular-related diseases in a subject in need thereof.

Drugs covered by this patent

Patent Metadata

Patent number
CA3026006C
Jurisdiction
CA
Classification
—
Expires
2021-09-07
Drug substance claim
No
Drug product claim
No
Assignee
Amarin Pharmaceuticals Ireland Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.